Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Associate Partners:

  • Kotak Mutual Fund
  • Pharmeasy
  • Indiabulls
  • SBI

Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Technology Partner

Dell Technologies

Associate Partners

Kotak Mutual Fund
Pharmeasy
Indiabulls
SBI
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Granules India

Granules India

BSE: 532482|NSE: GRANULES|ISIN: INE101D01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 25, 16:00
301.05
-3.85 (-1.26%)
VOLUME 136,103
LIVE
NSE
Jan 25, 15:59
301.15
-3.6 (-1.18%)
VOLUME 2,051,774
News on Granules India
Select Year: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Granules' US unit gets two USFDA observations

12.40 pm | 29 Oct 2018 |  Source: PTI

"Granules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company located in Chantilly, Virginia, US has completed USFDA (US Food and Dr...

Granules India Q2 PAT seen up 4.4% YoY to Rs. 40 cr: HDFC Securities

6.27 pm | 17 Oct 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 18.5 percent Y-o-Y (up 2.6 percent Q-o-Q) to Rs. 470 crore, according to HDFC Securities....

Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term 

8.26 am | 02 Aug 2018 |  Source: Moneycontrol.com

Mitessh Thakkar of mitesshthakkar.com recommends buying KPIT Technologies with a stop loss of Rs 301 and target of Rs 320 and Sun Pharmaceutical Indus...

Buy Granules India: Motilal Oswal

2.20 pm | 26 Jul 2018 |  Source: Moneycontrol.com

Granules India 1QFY19 sales grew 17 percent YoY to Rs 450 crore, led by finished dosages and APIs....

Granules India Q1 net profit up 41% to Rs 51.7 crore

9.48 pm | 23 Jul 2018 |  Source: PTI

The consolidated revenue from the operations of the company stood at Rs 453.23 crore for the quarter under consideration as against Rs 384.73 crore fo...

Buy Granules India; target of Rs 97: Geojit

3.27 pm | 08 Jun 2018 |  Source: Moneycontrol.com

Geojit is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 97 in its research report dated May 30, 2018....

Buy Granules India; target of Rs 98: KR Choksey

4.35 pm | 06 Jun 2018 |  Source: Moneycontrol.com

KR Choksey recommended accumulate rating on Granules India with a target price of Rs 98 in its research report dated May 29, 2018....

Buy Granules India; target of Rs 150: Centrum Research

4.33 pm | 06 Jun 2018 |  Source: Moneycontrol.com

Centrum Research is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 150 in its research report dated May 3...

Buy Granules India; target of Rs 115: HDFC Securities

4.38 pm | 31 May 2018 |  Source: Moneycontrol.com

HDFC Securities is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 115 in its research report dated May 25...

Granules India reports 55% fall in Q4 net profit at Rs 20.4 crore

4.58 pm | 24 May 2018 |  Source: Moneycontrol.com

The company board recommended a final dividend of 25 paise per share of face value of Re 1 each for the financial year 2017-18....

Granules gets USFDA nod for postpartum haemorrhage prevention drug

10.58 am | 17 May 2018 |  Source: PTI

In a filing to BSE, Granules India said "the U S Food and Drug Administration (USFDA) has approved its abbreviated new drug applications (ANDA) for Me...

Granules receives USFDA approval for generic Methylergonovine tablets

8.57 am | 17 May 2018 |  Source: Moneycontrol.com

Granules India announced that the USFDA has approved its Abbreviated New Drug Applications (ANDA) for Methylergonovine 0.2 mg Tablets....

Granules India receives approval for ANDA for Methocarbamol Tablet

10.12 am | 08 May 2018 |  Source: Moneycontrol.com

The US Food & Drug Administration (US FDA) has approved the Abbreviated New DrugrnApplication (ANDA) filed by Granules India Limited for Methocarbamol...

Granules India Q4 PAT seen up 3% YoY to Rs. 37.4 cr: KR Choksey

3.31 pm | 23 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 21.8 percent Y-o-Y (up 5.4 percent Q-o-Q) to Rs. 432.7 crore, according to KR Choksey....

Granules India Q4 PAT may dip 13.3% YoY to Rs. 40 cr: HDFC Securities

1.47 pm | 20 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 16.5 percent Y-o-Y (up 0.7 percent Q-o-Q) to Rs. 410 crore, according to HDFC Securities....

Granules India's Gagillapur and Jeedimetla facilities completed USFDA inspection

9.34 am | 26 Mar 2018 |  Source: Moneycontrol.com

Granules India's Gagillapur and Jeedimetla facilities located at Hyderabad, Telangana has completed USFDA inspection from March 19 to March 23, 20...

Granules India Limited

12.20 pm | 23 Mar 2018 |  Source: Moneycontrol.com

Krishna Prasad Chigurupati has submitted to the Exchange a copy of disclosure under Regulations 10 (6) of the SEBI (Substantial Acquisition of Shares ...

Buy Granules India, Hindustan Unilever, Ramco Cements, HCL Tech; hold Future Consumer: Sudarshan Sukhani 

12.18 pm | 10 Jan 2018 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Granules India, Hindustan Unilever, Ramco Cements and HCL Tech and can hold Futur...

1
Quick Links for Granules India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.